Prospective Comparison of Infective Endocarditis in Khon Kaen, Thailand and Rennes, France

Watt, George; Lacroix, Adèle; Pachirat, Orathai; Baggett, Henry C.; Raoult, Didier; Fournier, Pierre‐Edouard; Tattevin, Pierre

doi:10.4269/ajtmh.14-0689

Cited by 21 publications

(17 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In developed countries, the proportion of cases related to rheumatic heart disease has declined to 5% or less in the past 2 decades 4 . In developing countries, however, rheumatic heart disease remains the most common predisposing cardiac condition for IE 8 .…”

Section: Epidemiologymentioning

confidence: 99%

Infective endocarditis

Holland

Baddour

Bayer³

et al. 2016

Nat Rev Dis Primers

342

278

View full text Add to dashboard Cite

Infective endocarditis (IE) is a rare, life-threatening disease that has long-lasting effects even among patients who survive and are cured. IE disproportionately affects those with underlying structural heart disease and is increasingly associated with healthcare contact, particularly in patients who have intravascular prosthetic material. In the setting of bacteraemia with a pathogenic organism, an infected vegetation may form as the end result of complex interactions between invading microorganisms and the host immune system. Once established, IE can involve almost any organ system in the body. The diagnosis of IE may be difficult to establish and a strategy that combines clinical, microbiological and echocardiography results has been codified in the modified Duke criteria. In cases of blood culture-negative IE, the diagnosis may be especially challenging and novel microbiological and imaging techniques have been developed to establish its presence. Once diagnosed, IE is best managed by a multidisciplinary team with expertise in infectious diseases, cardiology and cardiac surgery. Antibiotic prophylaxis for the prevention of IE remains controversial. Efforts to develop a vaccine targeting common bacterial causes of IE are ongoing, but have not yet yielded a commercially available product.

show abstract

Section: Epidemiologymentioning

confidence: 99%

Infective endocarditis

Holland

Baddour

Bayer³

et al. 2016

Nat Rev Dis Primers

342

278

View full text Add to dashboard Cite

show abstract

“…Fatality in the study group was 7.5% compared to the incidence of death cases reported in the literature 18-20% for community acquired endocarditis, and 25-50% of nosocomial endocarditis [11,14,15,18]. …”

Section: Discussionmentioning

confidence: 85%

“…Similarly, in other studies, as a consequence of changes in the population at risk for IE, the average age of patients increased gradually from 30 -40 years old in the preantibiotic and initial antibiotic era to 47 -64 years old in recent decades. [14].…”

Section: Discussionmentioning

confidence: 95%

See 1 more Smart Citation

Infective Endocarditis – An Observational Study

Ţilea

Teches

Voidăzan

et al. 2015

ARS Medica Tomitana

View full text Add to dashboard Cite

Introduction: Despite all the progresses made in the management of infectious and cardiovascular diseases, the incidence of infective endocarditis remains high. Aim: the assessment of etiological, clinical, therapeutic aspects in patients with endocarditis. Material and method: A retrospective observational study in 40 patients with infective endocarditis was conducted, over a period of 5 years. Parameters related to demographic, risk factors, clinical aspects, nature and location of valve damage, bacteriological and therapeutic parameters were assessed. Echocardiography was used to confirm the location of the endocarditis; the aetiology of the disease was identified through the isolation of bacteria from blood cultures by using an automatic BacT/ALERT® system. Results: Patients' age ranged between 31 -84 years old. The disease was present predominantly in male patients (67.5%). 70% of the patients were positively diagnosed with endocarditis and 30% with possible endocarditis; the most frequent localization was the native valves in 75% of the cases, compared to the localization in the prosthetic valves, 25%; the aortic valve was involved in 60% of the cases, mitral valve in 40% of the patients.

show abstract

“…Fewer patients can go to surgical treatment and mortality is higher than in younger patients [7,13,15,16,23].…”

Section: Elderly Patientsmentioning

confidence: 99%

Infective Endocarditis in End-Stage Renal Disease Patients in Developing Countries: What is the Real Problem?

Rafael¹,

Anabel²,

Jesús³

et al. 2016

Contemporary Challenges in Endocarditis

View full text Add to dashboard Cite

The epidemiology of infective endocarditis (IE) has changed over the last decades, due to various factors. This chapter focuses on IE in patients with end-stage renal disease. Then it reviews the most relevant reports published in the last decade worldwide; the different scenarios in developing countries versus developed countries; different microorganisms, treatment times, and outcomes; and also our own experience in these patients. Finally, it mentions the recommendations that have helped some developed countries to reduce more than 50% of bacteremia in catheter patients and how to make them possible in developing countries.

show abstract

Prospective Comparison of Infective Endocarditis in Khon Kaen, Thailand and Rennes, France

Cited by 21 publications

References 24 publications

Infective endocarditis

Infective endocarditis

Infective Endocarditis – An Observational Study

Infective Endocarditis in End-Stage Renal Disease Patients in Developing Countries: What is the Real Problem?

Contact Info

Product

Resources

About